share_log

公告精选 | 中远海控预计三季度净利增逾280%;石药集团达成近20亿美元药物授权协议

Selected Announcements | Cosco Shipping Holdings expects a net profit increase of over 280% in the third quarter; cspc pharma reaches a nearly 2 billion US dollar drug authorization agreement.

cls.cn ·  Oct 8 08:15

Important Announcement for Hong Kong Stocks.

1) Company News

$COSCO SHIP HOLD (01919.HK)$Estimated net income for the first three quarters is about 38.121 billion yuan, a year-on-year increase of about 72.72%. Among them, the net income for the third quarter is about 21.251 billion yuan, a year-on-year increase of about 285.66%. Mainly due to the third quarter, as the peak season for the European and American main trunk routes market, the company's container shipping business achieved a simultaneous rise in volume and price.

$OOIL (00316.HK)$Total revenue and total cargo volume for the first three quarters increased by 23.4% and 2.6% year-on-year, respectively. The overall load factor increased by 3.0% year-on-year, and the average revenue per standard container increased by 20.3%. Among them, total revenue in the third quarter increased by 73.7%, reaching 3.056 billion US dollars.

$GWMOTOR (02333.HK)$Approximately 0.8538 million units were sold in the first 9 months, a decrease of 1.18% year-on-year; among them, approximately 0.1084 million units were sold in September, a decrease of 10.88% year-on-year.

$CSPC PHARMA (01093.HK)$Signed an exclusive licensing agreement with Astrazeneca for YS2302018.

According to the agreement, the company agrees to grant Astrazeneca exclusive rights to develop, manufacture, and commercialize the compound and the product globally. The group will receive a prepayment of 0.1 billion US dollars, and is entitled to receive up to 0.37 billion US dollars in potential development milestone payments and up to 1.55 billion US dollars in potential sales milestone payments, as well as tiered sales royalties based on the annual net sales of the product.

$ASCLETIS-B (01672.HK)$Received a preliminary ruling from the ITC on the legal disputes involving ASC41 and ASC43F.

$GREENTOWN CHINA (03900.HK)$The cumulative contract sales amount for the first 9 months is approximately 187.2 billion yuan, a decrease of 2.65% year-on-year.

$POLY PROPERTY (00119.HK)$In the first nine months, the cumulative contract sales amounted to 40.2 billion yuan, a decrease of 12.42% year-on-year.

$GEMDALE PPT (00535.HK)$In the first nine months, the cumulative contract sales amounted to 14.177 billion yuan, a decrease of 48.4% year-on-year.

$RSUN PPT (01996.HK)$In the first nine months, the cumulative contract sales amounted to 6.67 billion yuan, a decrease of 64.7% year-on-year.

2) Repurchase Dynamics

$TENCENT (00700.HK)$Invested approximately 0.502 billion Hong Kong dollars to repurchase 1.05 million shares at a repurchase price of 470-482.2 Hong Kong dollars.

$HSBC HOLDINGS (00005.HK)$Swire Pacific A spent approximately 0.248 billion Hong Kong dollars to repurchase 3.5636 million shares at a repurchase price of 69.2-69.95 Hong Kong dollars.

$SWIRE PACIFIC A (00019.HK)$Spent 16.046 million Hong Kong dollars to repurchase 0.2305 million shares at a repurchase price of 11.02-11.14 Hong Kong dollars.

Editor/ping

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment